Benzamide

Benzamide

SCHEMBL5320681

CC(C)(C)OC(N)=O.NC(=O)c1ccccc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 4/20 0.61
▸ TSHR P16473 3/20 0.61
▸ HSD17B10 Q99714 2/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ MAPT P10636 2/20 0.61
▸ POLB P06746 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ RECQL P46063 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ PMP22 Q01453 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ PARP10 Q53GL7 7/20 0.49
▸ ALDH1A1 P00352 2/20 0.47
▸ PLA2G10 O15496 1/20 0.44
▸ PLA2G2A P14555 1/20 0.44
▸ KMT2A Q03164 3/20 0.42
▸ PARP4 Q9UKK3 2/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL999801 0.89 TSHR (0.54) PARP1TSHRHSD17B10TDP1MAPT
Benzene SCHEMBL27546891 0.83 KMT2A (0.39) TSHRHSD17B10TDP1MAPTCYP2C19
Toluene SCHEMBL26697033 0.82 TSHR (0.44) PARP1TSHRHSD17B10TDP1MAPT
Aniline SCHEMBL27495165 0.82 TSHR (0.44) PARP1TSHRHSD17B10TDP1MAPT
Benzamide SCHEMBL28302953 0.82 TSHR (0.53) PARP1TSHRHSD17B10TDP1MAPT
Aniline SCHEMBL28104783 0.81 KMT2A (0.42) PARP1TSHRHSD17B10TDP1MAPT
Chlorobenzene SCHEMBL27484099 0.81 KMT2A (0.42) PARP1TSHRHSD17B10TDP1MAPT
Fluorobenzene SCHEMBL27926129 0.81 KCNN4 (0.46) PARP1TSHRHSD17B10TDP1MAPT
Benzamide SCHEMBL29825021 0.79 PARP1 (0.73) PARP1TSHRHSD17B10TDP1MAPT
Benzamide SCHEMBL2061911 0.79 PARP1 (0.89) PARP1TSHRHSD17B10TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101203499-A Alkyl sulfonamide derivatives LUNDBECK AS CO H (DK) 2008-06-18 — — CN disclosed
WO-2007103295-A2 HALOGENATED SULFONAMIDE DERIVATIVES H. LUNDBECK A/S (DK) 2007-09-13 — — WO disclosed
US-20070213376-A1 Halogenated sulfonamide derivatives H. LUNDBECK A/S (DK) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213376-A1 Halogenated sulfonamide derivatives NPY5R, NPY2R, SSTR5 PARP1 4712/4885TSHR 37/4885HSD17B10 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback